Du är här

2014-05-19

Ad hoc: Biofrontera AG - Biofrontera AG moves to Prime Standard and acquires additional listing on the London Stock Exchange

Biofrontera AG / Keyword(s): Misc. matters /Ad hoc: Biofrontera AG -
Biofrontera AG moves to Prime Standard and acquires additional listing on the
London Stock Exchange. Ad hoc announcement according to § 15 WpHG. Processed
and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely
responsible for the content of this announcement.
Leverkusen, Germany, 19 May 2014 -The management board of Biofrontera AG
(Biofrontera) has resolved today, with the approval of the supervisory board,
to apply to the Frankfurt Stock Exchange to list its shares in the "Prime
Standard" segment. Currently, the shares of Biofrontera are listed in the
regulated market segment "General Standard". The segment "Prime Standard"
enacts additional transparency requirements for the benefit of shareholders.

At the same time, it was resolved to acquire an additional listing of the
shares of Biofrontera on the Alternative Investment Market (AIM) segment of
the London Stock Exchange, in order to facilitate better access to the
international capital markets and to improve the trading liquidity of the
shares. UK institutional investors have requested, in many cases, a listing
on AIM as a precondition for an investment in Biofrontera.
The listing at the AIM is effected in cooperation with the investment firm
FinnCap, London, which will also function as nominated advisor and broker in
respect of trading on the London Stock Exchange.

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611

Contact:
Biofrontera AG
Tel.: +49 (0214) 87 63 2 22, Fax.: +49 (0214) 87 63 290
E-mail:press@biofrontera.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biofrontera AG via Globenewswire

HUG#1786776

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.